title: CA 125 half-life breakpoint between a "good" and "poor" prognosis in patients with ovarian cancer.
authors.affiliation: Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, 3000-295 Coimbra, Portugal.
authors.forename: A
authors.initials: A
authors.lastname: Mano
authors.forename: I
authors.initials: I
authors.lastname: Godinho
authors.forename: A C
authors.initials: AC
authors.lastname: Falcão
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018394:CA-125 Antigen / Q000097:blood*; D005260:Female; D006207:Half-Life; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000097:blood* / Q000401:mortality; D011379:Prognosis; D016019:Survival Analysis
chemical_list: D018394:CA-125 Antigen